These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1309 related items for PubMed ID: 16511772

  • 1. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P, Martín-Carbonero L, Núñez M, Rivas P, Morente A, Simarro N, Labarga P, González-Lahoz J, Soriano V.
    Clin Infect Dis; 2006 Apr 01; 42(7):1032-9. PubMed ID: 16511772
    [Abstract] [Full Text] [Related]

  • 2. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    Martin-Carbonero L, de Ledinghen V, Moreno A, Maida I, Foucher J, Barreiro P, Romero M, Satta G, Garcia-Samaniego J, Gonzalez-Lahoz J, Soriano V.
    J Viral Hepat; 2009 Nov 01; 16(11):790-5. PubMed ID: 19413693
    [Abstract] [Full Text] [Related]

  • 3. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
    Sánchez-Conde M, Berenguer J, Miralles P, Alvarez F, Carlos Lopez J, Cosin J, Pilar C, Ramirez M, Gutierrez I, Alvarez E.
    Clin Infect Dis; 2006 Sep 01; 43(5):640-4. PubMed ID: 16886160
    [Abstract] [Full Text] [Related]

  • 4. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY, Dai CY, Lee LP, Huang JF, Tsai WC, Hou NJ, Lin ZY, Chen SC, Wang LY, Chang WY, Chuang WL, Yu ML.
    J Clin Pathol; 2008 Mar 01; 61(3):333-7. PubMed ID: 17545561
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G, Vario A, Ferrari A, Pistis R, Noventa F, Alberti A.
    J Viral Hepat; 2006 Mar 01; 13(3):199-205. PubMed ID: 16475996
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
    Castéra L, Loko MA, Le Bail B, Coffie P, De Ledinghen V, Trimoulet P, Winnock M, Dabis F, Neau D, Groupe D'epidémiologie Clinique du Sida en Aquitaine (GECSA).
    Aliment Pharmacol Ther; 2007 Dec 01; 26(11-12):1489-98. PubMed ID: 17903235
    [Abstract] [Full Text] [Related]

  • 10. Ribavirin in the treatment of hepatitis C.
    Abonyi ME, Lakatos PL.
    Anticancer Res; 2005 Dec 01; 25(2B):1315-20. PubMed ID: 15865084
    [Abstract] [Full Text] [Related]

  • 11. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P, Pénaranda G, Carrat F, Bedossa P, Bourlière M, Ouzan D, Renou C, Tran A, Rosenthal E, Wartelle C, Delasalle P, Cacoub P.
    Aliment Pharmacol Ther; 2009 Jul 01; 30(1):61-70. PubMed ID: 19292832
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
    Picchio GR, Nakatsuno M, Boggiano C, Sabbe R, Corti M, Daruich J, Pérez-Bianco R, Tezanos-Pinto M, Kokka R, Wilber J, Mosier D.
    J Med Virol; 1997 Jun 01; 52(2):219-25. PubMed ID: 9179772
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V, Puoti M, Mussini C, Bellelli S, Angeletti C, Sabbatini F, Prati F, Cossarizza A, Esposito R.
    Antivir Ther; 2008 Jun 01; 13(8):1057-65. PubMed ID: 19195331
    [Abstract] [Full Text] [Related]

  • 17. Predictors of histological activity and fibrosis in chronic Hepatitis C infection: a study from North India.
    Singh S, Gupta R, Malhotra V, Sarin SK.
    Indian J Pathol Microbiol; 2010 Jun 01; 53(2):238-43. PubMed ID: 20551524
    [Abstract] [Full Text] [Related]

  • 18. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM, Benmousa A, Al-Hussaini H, Ashraf S, Alhafi O, Abdo AA, Alameri HF, Akbar HO, Bzeizi KI.
    Liver Int; 2008 Aug 01; 28(7):1011-8. PubMed ID: 18384520
    [Abstract] [Full Text] [Related]

  • 19. Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting.
    Reiberger T, Obermeier M, Payer BA, Baumgarten A, Weitner L, Moll A, Christensen S, Köppe S, Kundi M, Rieger A, Peck-Radosavljevic M.
    Antivir Ther; 2011 Aug 01; 16(6):815-24. PubMed ID: 21900713
    [Abstract] [Full Text] [Related]

  • 20. Factors associated with severity and disease progression in chronic hepatitis C.
    Tassopoulos NC, Papatheodoridis GV, Katsoulidou A, Delladetsima JK, Sypsa V, Touloumi G, Nikandros M, Hatzakis A.
    Hepatogastroenterology; 1998 Aug 01; 45(23):1678-83. PubMed ID: 9840128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.